{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:19:41Z","timestamp":1792023581482,"version":"4.4.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81902939"],"award-info":[{"award-number":["81902939"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hepatobiliary & Pancreatic Diseases International"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.hbpd.2020.02.005","type":"journal-article","created":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T04:48:13Z","timestamp":1582260493000},"page":"138-146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Transarterial chemoembolization versus percutaneous microwave coagulation therapy for recurrent unresectable intrahepatic cholangiocarcinoma: Development of a prognostic nomogram"],"prefix":"10.1016","volume":"19","author":[{"given":"Yang","family":"Ge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seogsong","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gui-Juan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Bin","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bao-Hua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-Bao","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Jun","family":"Sui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Yang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hbpd.2020.02.005_bib0001","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1016\/S0140-6736(13)61903-0","article-title":"Cholangiocarcinoma","volume":"383","author":"Razumilava","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.hbpd.2020.02.005_bib0002","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1634\/theoncologist.2015-0446","article-title":"Forty-year trends in cholangiocarcinoma incidence in the U.S.: intrahepatic disease on the rise","volume":"21","author":"Saha","year":"2016","journal-title":"Oncologist"},{"key":"10.1016\/j.hbpd.2020.02.005_bib0003","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/hep.28744","article-title":"Liver transplantation for \u201cvery early\u201c intrahepatic cholangiocarcinoma: international retrospective study supporting a prospective assessment","volume":"64","author":"Sapisochin","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.hbpd.2020.02.005_bib0004","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S2468-1253(18)30045-1","article-title":"Liver transplantation for locally advanced intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: a prospective case-series","volume":"3","author":"Lunsford","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.hbpd.2020.02.005_bib0005","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1200\/JCO.2011.35.6519","article-title":"Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment","volume":"29","author":"de Jong","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.hbpd.2020.02.005_bib0006","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/SLA.0b013e318176c4d3","article-title":"Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection","volume":"248","author":"Endo","year":"2008","journal-title":"Ann Surg"},{"key":"10.1016\/j.hbpd.2020.02.005_bib0007","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nrclinonc.2017.157","article-title":"Cholangiocarcinoma - evolving concepts and therapeutic strategies","volume":"15","author":"Rizvi","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.hbpd.2020.02.005_bib0008","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/ijc.26407","article-title":"Transarterial chemoembolization in the treatment of patients with unresectable cholangiocarcinoma: results and prognostic factors governing treatment success","volume":"131","author":"Vogl","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.hbpd.2020.02.005_bib0009","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1080\/02656736.2017.1327678","article-title":"Clinical and survival outcomes of percutaneous microwave ablation for intrahepatic cholangiocarcinoma","volume":"34","author":"Zhang","year":"2018","journal-title":"Int J Hyperthermia"},{"key":"10.1016\/j.hbpd.2020.02.005_bib0010","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s00270-012-0463-4","article-title":"Yttrium-90 radioembolization for unresectable standard-chemorefractory intrahepatic cholangiocarcinoma: survival, efficacy, and safety study","volume":"36","author":"Rafi","year":"2013","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.hbpd.2020.02.005_bib0011","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1200\/JCO.2015.64.2710","article-title":"Multi-institutional phase II study of high-dose hypofractionated proton beam therapy in patients with localized, unresectable hepatocellular carcinoma and intrahepatic cholangiocarcinoma","volume":"34","author":"Hong","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.hbpd.2020.02.005_bib0012","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S1470-2045(14)70212-8","article-title":"Gemcitabine and oxaliplatin with or without cetuximab in advanced biliary-tract cancer (BINGO): a randomised, open-label, non-comparative phase 2 trial","volume":"15","author":"Malka","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.hbpd.2020.02.005_bib0013","doi-asserted-by":"crossref","first-page":"558","DOI":"10.3109\/02656736.2013.821528","article-title":"Radiofrequency ablation for hepatocellular carcinoma","volume":"29","author":"Nishikawa","year":"2013","journal-title":"Int J Hyperthermia"},{"key":"10.1016\/j.hbpd.2020.02.005_bib0014","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.surg.2016.10.024","article-title":"Effectiveness of repeat hepatic resection for patients with recurrent intrahepatic cholangiocarcinoma: factors associated with long-term outcomes","volume":"161","author":"Si","year":"2017","journal-title":"Surgery"},{"key":"10.1016\/j.hbpd.2020.02.005_bib0015","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1002\/sim.2277","article-title":"Interval estimation for treatment effects using propensity score matching","volume":"25","author":"Hill","year":"2006","journal-title":"Stat Med"},{"key":"10.1016\/j.hbpd.2020.02.005_bib0016","doi-asserted-by":"crossref","first-page":"55","DOI":"10.7326\/M14-0697","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the tripod statement","volume":"162","author":"Collins","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.hbpd.2020.02.005_bib0017","doi-asserted-by":"crossref","first-page":"83806","DOI":"10.18632\/oncotarget.11514","article-title":"Retrospective analysis of transarterial chemoembolization and sorafenib in Chinese patients with unresectable and recurrent hepatocellular carcinoma","volume":"7","author":"Wan","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.hbpd.2020.02.005_bib0018","doi-asserted-by":"crossref","first-page":"e11618","DOI":"10.1097\/MD.0000000000011618","article-title":"Clinical outcome in elderly Chinese patients with primary hepatocellular carcinoma treated with percutaneous microwave coagulation therapy (PMCT): a strobe-compliant observational study","volume":"97","author":"Shen","year":"2018","journal-title":"Medicine"},{"key":"10.1016\/j.hbpd.2020.02.005_bib0019","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.hbpd.2020.02.005_bib0020","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life-tables","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc B"},{"key":"10.1016\/j.hbpd.2020.02.005_bib0021","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1200\/JCO.2014.60.1153","article-title":"Localized and systemic approaches to treating hepatocellular carcinoma","volume":"33","author":"Knox","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.hbpd.2020.02.005_bib0022","first-page":"621","article-title":"Percutaneous microwave coagulation therapy for hepatocellular carcinoma: increased coagulation diameter using a new electrode and microwave generator","volume":"24","author":"Inokuchi","year":"2010","journal-title":"Oncol Rep"},{"key":"10.1016\/j.hbpd.2020.02.005_bib0023","doi-asserted-by":"crossref","first-page":"S159","DOI":"10.1067\/msy.2002.119498","article-title":"Intrahepatic cholangiocarcinoma: its mode of spreading and therapeutic modalities","volume":"131","author":"Shirabe","year":"2002","journal-title":"Surgery"},{"key":"10.1016\/j.hbpd.2020.02.005_bib0024","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.jvir.2013.02.031","article-title":"Yttrium-90 radioembolization for intrahepatic cholangiocarcinoma: safety, response, and survival analysis","volume":"24","author":"Mouli","year":"2013","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.hbpd.2020.02.005_bib0025","doi-asserted-by":"crossref","first-page":"105","DOI":"10.21037\/hbsn.2017.01.16","article-title":"Management of unresectable intrahepatic cholangiocarcinoma: how do we decide among the various liver-directed treatments?","volume":"6","author":"Koay","year":"2017","journal-title":"Hepatobiliary Surg Nutr"},{"key":"10.1016\/j.hbpd.2020.02.005_bib0026","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1002\/hep.30289","article-title":"Intrahepatic cholangiocarcinoma: continuing challenges and translational advances","volume":"69","author":"Sirica","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.hbpd.2020.02.005_bib0027","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1200\/JCO.2012.41.5984","article-title":"Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy","volume":"31","author":"Wang","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.hbpd.2020.02.005_bib0028","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1186\/s12885-017-3464-5","article-title":"Risk stratification system to predict recurrence of intrahepatic cholangiocarcinoma after hepatic resection","volume":"17","author":"Jeong","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.hbpd.2020.02.005_bib0029","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2017.0117","article-title":"Development and validation of a prognostic score for intrahepatic cholangiocarcinoma","volume":"152","author":"Raoof","year":"2017","journal-title":"JAMA Surg"},{"key":"10.1016\/j.hbpd.2020.02.005_bib0030","series-title":"PDQ cancer information summaries","article-title":"Bile duct cancer (cholangiocarcinoma) treatment (PDQ\u24c7): health professional version","year":"2002"},{"key":"10.1016\/j.hbpd.2020.02.005_bib0031","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.bbadis.2017.07.028","article-title":"The deleterious interplay between tumor epithelia and stroma in cholangiocarcinoma","volume":"1864","author":"Cadamuro","year":"2018","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.hbpd.2020.02.005_bib0032","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/bjs.10676","article-title":"Early versus late recurrence of intrahepatic cholangiocarcinoma after resection with curative intent","volume":"105","author":"Zhang","year":"2018","journal-title":"Br J Surg"},{"key":"10.1016\/j.hbpd.2020.02.005_bib0033","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S1072-7515(01)01016-X","article-title":"Intrahepatic cholangiocarcinoma: resectability, recurrence pattern, and outcomes","volume":"193","author":"Weber","year":"2001","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.hbpd.2020.02.005_bib0034","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jamcollsurg.2016.05.019","article-title":"Recurrence patterns and disease-free survival after resection of intrahepatic cholangiocarcinoma: preoperative and postoperative prognostic models","volume":"223","author":"Doussot","year":"2016","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.hbpd.2020.02.005_bib0035","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1245\/s10434-016-5751-9","article-title":"Prognosis of intrahepatic cholangiocarcinomas with HBV infection is better than those with hepatolithiasis after R0 liver resection: a propensity score matching analysis","volume":"24","author":"Wang","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hbpd.2020.02.005_bib0036","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1007\/s00268-016-3843-0","article-title":"Low incidence of lymph node metastasis after resection of hepatitis virus-related intrahepatic cholangiocarcinoma","volume":"41","author":"Iida","year":"2017","journal-title":"World J Surg"}],"container-title":["Hepatobiliary & Pancreatic Diseases International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499387220300357?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499387220300357?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T15:41:13Z","timestamp":1761493273000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1499387220300357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S1499387220300357"],"URL":"https:\/\/doi.org\/10.1016\/j.hbpd.2020.02.005","relation":{},"ISSN":["1499-3872"],"issn-type":[{"value":"1499-3872","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transarterial chemoembolization versus percutaneous microwave coagulation therapy for recurrent unresectable intrahepatic cholangiocarcinoma: Development of a prognostic nomogram","name":"articletitle","label":"Article Title"},{"value":"Hepatobiliary & Pancreatic Diseases International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hbpd.2020.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 First Affiliated Hospital, Zhejiang University School of Medicine in China. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}